...
首页> 外文期刊>Journal of Ethnopharmacology: An Interdisciplinary Journal Devoted to Bioscientific Research on Indigenous Drugs >The epigallocatechin gallate derivative Y-6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/HIF-1 alpha/VEGF dependent pathways
【24h】

The epigallocatechin gallate derivative Y-6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/HIF-1 alpha/VEGF dependent pathways

机译:EpigallocaTechin诱导衍生物Y-6通过抑制MAPK / ERK1 / 2和PI3K / AKT / HIF-1α/ VEGF依赖性途径中的血管生成来抑制人肝细胞癌

获取原文
获取原文并翻译 | 示例

摘要

Ethnopharmacological relevance: Hypervascularity has been considered as one of the major features of many solid tumors. Green tea is one of the commonly drink resources in China, and its active component, Epigallocatechin gallate (EGCG), exhibits antiangiogenic activities in various experimental tumor models. However, EGCG has many shortages, e.g., relatively unstable, low lipid solubility, poor bioavailability, and short duration of action.
机译:民族科医药相关性:高血压血管被认为是许多实体肿瘤的主要特征之一。 绿茶是中国的常见饮酒资源之一,其活性成分EpigallocateChin Gallate(EGCG),在各种实验肿瘤模型中表现出抗血管生成活性。 然而,EGCG具有许多短缺,例如,相对不稳定,低脂质溶解度,生物利用度差和短暂的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号